ストックスクリーナーアプリを入手
1.18
2.61%
0.03
プレマーケット:
1.18
Geron Corp (GERN) 最新ニュース
Why Did GERN Stock Tumble 10% Pre-Market Today? - Stocktwits
GERN Stock Builds Momentum On Strong RYTELO Data - StocksToTrade
Geron Corp stock (US3741631036): Phase 3 data keeps focus on first commercial launch - AD HOC NEWS
Earnings call transcript: Geron Q1 2026 shows revenue growth, stock rises - Investing.com
Geron Corp stock (US3741631036): Focus on valuation as short interest eases - AD HOC NEWS
GERN Stock Chart | GERON CORP (NASDAQ:GERN) - ChartMill
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN) - Yahoo Finance
GERN SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Yahoo Finance
Geron plans Goldman Sachs healthcare fireside chat, webcast June 8 - Stock Titan
1GERN.MI Technical Analysis | Trend, Signals & Chart Patterns | GERON CORP (BIT:1GERN) - ChartMill
Geron Shareholders Expand Equity Plan and Elect Directors - The Globe and Mail
Geron (NASDAQ: GERN) adds 4.5M shares to 2018 equity incentive plan - Stock Titan
Geron (NASDAQ: GERN) director awarded 220,000 options at $1.26 strike - Stock Titan
Geron (NASDAQ: GERN) director awarded stock options for 220,000 shares at $1.26 - Stock Titan
Geron (GERN) awards director Susan Molineaux 220,000 stock options - Stock Titan
Geron (GERN) director granted 220,000 stock options at $1.26 - Stock Titan
Geron (GERN) director Dawn Carter Bir awarded 220,000 stock options - Stock Titan
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets - Benzinga
GERN: All proposals passed; clinical and commercial strategies advancing, with key trial data ahead - TradingView
Geron Corporation’s SWOT analysis: biotech stock faces sales headwinds - Investing.com
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo! Finance Canada
Geron Corp stock (US3741631036): new stock option grants keep hiring momentum in focus - AD HOC NEWS
Five new Geron hires receive options for 333,750 shares - Stock Titan
Shareholders of Geron Corporation Should Contact The Gross Law F - GuruFocus
GERN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Deep Track (GERN) reports 31.7M shares, 4.95% ownership (May 2026) - Stock Titan
TradingKey - TradingKey
Geron reports Q1 revenue growth and updates on blood cancer drug progress. - Pluang
Geron Corporation Announces Positive Real-World Evidence Study of RYTELO® in Lower-Risk Myelodysplastic Syndromes Ahead of EHA 2026 Presentations - Quiver Quantitative
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 - ChartMill
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy? - Insider Monkey
10 Best US Stocks Under $5 to Buy - Insider Monkey
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Soleus group discloses 41.51M GERN shares (6.5%) — Soleus/Guy Levy - Stock Titan
A Look At Geron (GERN) Valuation After Q1 Results And Reaffirmed 2026 Guidance - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q1 2026 Earnings Call Transcript - Insider Monkey
Geron Corporation (NASDAQ:GERN): Is Breakeven Near? - Moomoo
Can Geron’s (GERN) Narrowing Losses Reframe Expectations For Its Blood Cancer Earnings Potential? - simplywall.st
Geron (GERN) Q1 2026 Earnings Call Transcript - AOL.com
Geron Corporation Q1 2026 Financial Results: Revenue, Net Loss, and SEC Filing Insights - Minichart
symbol__ Stock Quote Price and Forecast - CNN
Geron Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Geron: Q1 Earnings Snapshot - theheraldreview.com
[10-Q] GERON CORP Quarterly Earnings Report - Stock Titan
Geron Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Geron (GERN) reports Q1 loss, beats revenue estimates - MSN
Geron Q1 Earnings Call Highlights - Yahoo Finance
Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues - ChartMill
Geron Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
GERON ($GERN) Releases Q1 2026 Earnings - Quiver Quantitative
$341M cash and $51.8M Q1 sales keep Geron on its 2026 path - Stock Titan
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire
MSN Money - MSN
Geron earnings loom: Can RYTELO revenue sustain commercial momentum? By Investing.com - Investing.com Canada
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):